Invention Grant
- Patent Title: Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
-
Application No.: US16304217Application Date: 2017-05-25
-
Publication No.: US11213495B2Publication Date: 2022-01-04
- Inventor: Hwei-Hsien Chen
- Applicant: NATIONAL HEALTH RESEARCH INSTITUTES , Hsing-Jien Kung
- Applicant Address: TW Zhunan Town; TW Zhuhan Town
- Assignee: NATIONAL HEALTH RESEARCH INSTITUTES,Hsing-Jien Kung
- Current Assignee: NATIONAL HEALTH RESEARCH INSTITUTES,Hsing-Jien Kung
- Current Assignee Address: TW Zhunan Town; TW Zhuhan Town
- Agency: Muncy, Geissler, Olds and Lowe, P.C.
- International Application: PCT/US2017/034542 WO 20170525
- International Announcement: WO2017/205666 WO 20171130
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61P25/30 ; A61P25/24 ; A61K31/205
Abstract:
The present invention relates to a method for decreasing the psychotomimetic side effects and enhancing the antidepressant-like effects of ketamine by the combination of ketamine with a methylglycine derivative. The present invention also relates to a method for depression treatment comprising administrating ketamine combined with a methylglycine derivative. The present invention further provides a method for preventing or treating addictive disorders of ketamine by administrating a methylglycine derivative.
Public/Granted literature
- US20200069610A1 METHOD AND COMPOSITION FOR DECREASING THE PSYCHOTOMIMETIC SIDE EFFECT AND ADDICTIVE DISORDER OF KETAMINE Public/Granted day:2020-03-05
Information query
